Slingshot members are tracking this event:
FDA Announces Black Box Requirement for Risk of HBV Reactivation for at Least 9 Brand Name Drugs in Hepatitis C Treatment
Slingshot Insights Explained
Oct 05, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Black Box Requirement, Hbv Reactivation, 9 Brand Name Drugs, Hepatitis C Treatment, Sovaldi, Harvoni, Viekira Pak, Zepatier